rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Meenu Chhabra

Director

Company insider

Files Form 4 as: Director, MacroGenics; Director, Apexigen; Director, GRI Bio; President and CEO, Proteostasis Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
36
Buys
1
Sells
1
Bought
$200K
Sold
$49K
Companies
4
Companies where not an officer
3
First trade
10 Feb 2016
Last trade
19 May 2026
Last filed
20 May 2026

Companies traded

Where they are an officer
Proteostasis TherapeuticsDirector, Officer · last 2 Mar 20201 buy · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
MGNX MacroGenicsDirector · Biotechnology · last 19 May 20260 buys · 0 sells
ApexigenDirector · last 23 Aug 20230 buys · 0 sells
GRI GRI BioDirector · Biotechnology · last 23 Feb 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—22,000 at $0.00filing
19 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—3,750 at $0.00filing
19 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—22,000 at $0.00filing
19 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—3,750 at $0.00filing
18 May 2026filed 20 May 2026MGNX MacroGenicsBiotechnologySEC FORM 4 Code M—3,750filing
18 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code M—3,750 at $0.00filing
18 May 2026filed 20 May 2026MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code M—3,750 at $0.00filing
18 May 2026filed 20 May 2026MGNX MacroGenicsBiotechnologySEC FORM 4 Code M—3,750filing
21 May 2025filed 22 May 2025MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—3,750 at $0.00filing
21 May 2025filed 22 May 2025MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—22,000 at $0.00filing
21 May 2025filed 22 May 2025MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A$63K49,213 at $1.27filing
20 May 2025filed 22 May 2025MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code M—6,500 at $0.00filing
20 May 2025filed 22 May 2025MGNX MacroGenicsBiotechnologySEC FORM 4 Code M—6,500filing
21 May 2024filed 23 May 2024MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
21 May 2024filed 23 May 2024MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—16,500 at $0.00filing
21 May 2024filed 23 May 2024MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A$63K17,077 at $3.66filing
20 May 2024filed 22 May 2024MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code M—4,500 at $0.00filing
20 May 2024filed 22 May 2024MGNX MacroGenicsBiotechnologySEC FORM 4 Code M—4,500 at $0.00filing
23 Aug 2023filed 25 Aug 2023Apexigenoption or derivativeSEC FORM 4 Code D—100,000filing
31 May 2023filed 2 Jun 2023MGNX MacroGenicsoption or derivative · BiotechnologySEC FORM 4 Code A—4,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.